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Abstract
Positive affect is associated with a number of health benefits; however, few studies have examined the relationship
between positive affect and cerebral glucose metabolism, a key energy source for neuronal function and a possible index of
brain health. We sought to determine if positive affect was associated with cerebral glucose metabolism in late middle-aged
adults (n ¼ 133). Participants completed the positive affect subscale of the Center for Epidemiological Studies Depression
Scale at two time points over a two-year period and underwent 18F-fluorodeoxyglucose-positron emission tomography
scanning. After controlling for age, sex, perceived health status, depressive symptoms, anti-depressant use, family history
of Alzheimer’s disease, APOE e4 status and interval between visits, positive affect was associated with greater cerebral glucose metabolism across para-/limbic, frontal, temporal and parietal regions. Our findings provide evidence that positive affect in late midlife is associated with greater brain health in regions involved in affective processing and also known to be
susceptible to early neuropathological processes. The current findings may have implications for interventions aimed at
increasing positive affect to attenuate early neuropathological changes in at-risk individuals.
Key words: positive affect; cerebral glucose metabolism; well-being; FDG-PET; health; neuroimaging

Introduction
Positive affect refers to pleasant emotional and mood states,
broadly experienced as happiness, enthusiasm, contentment,
coping, well-being and optimism (Folkman and Moskowitz,
2000; Lyubomirsky et al., 2005; Pressman and Cohen, 2005). Over
the past few decades research has provided evidence of the association between positive affect and beneficial outcomes

across many important psychosocial (Connolly and
Viswesvaran, 2000; Fredrickson et al., 2003; Kashdan and
Roberts, 2004; Lyubomirsky et al., 2005; Ruvolo, 1998; Wright and
Staw, 1999) and health domains (Boehm and Kubzansky, 2012;
Davidson et al., 2010; Ostir et al., 2001; Steptoe et al., 2005).
Furthermore, studies have demonstrated that positive affect
and related measures of happiness and well-being are associated with healthy aging and reduced mortality (Danner et al.,
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2001; Diener and Chan, 2011; Krijthe et al., 2011; Levy et al., 2002;
Moskowitz, 2003; Ostir et al., 2000; Steptoe et al., 2015; but see Liu
et al., 2016). While the direction of causality between positive affect and beneficial outcomes, particularly within the domains of
health and longevity (Liu et al., 2016; Lyubomirsky et al., 2005),
requires further evaluation, it is reasonable to postulate that
positive affect may also be associated with brain health.
Cerebral glucose metabolism, indexed by positron emission
tomography (PET) tracer 18F-fluorodeoxyglucose (18F-FDG), is
an in vivo measure that is widely used as a marker of brain
health and function in normal aging and disease. In normal
aging, decreases in cerebral metabolism have been observed in
anterior brain regions (Kalpouzos et al., 2009; Pardo et al., 2007;
Petit-Taboue et al., 1998) with more pronounced disruption of
metabolic processes within temporoparietal regions in neurodegenerative diseases such as Alzheimer’s disease (AD) (Dukart
et al., 2013; Kalpouzos et al., 2009; Yoshizawa et al., 2014).
Abnormal cerebral glucose metabolism has also been consistently observed within fronto-limbic regions in depression
(Drevets et al., 1997; Seminowicz et al., 2004), a disorder often
characterized by low levels of positive affect and high levels of
negative affect (Watson and Clark, 1997; Wichers et al., 2012).
Given the above evidence of age and disease-specific
changes in cerebral glucose metabolism as well as the beneficial
health outcomes associated with positive affect, it is possible
that levels of positive affect will also have an association with
cerebral glucose metabolism. To date, little is known about the
relationship between positive affect and brain health, particularly in midlife when interventions aimed at modifying risk factors for pathological aging may be most effective. In the current
study, we examined the relationship between positive affect
and cerebral glucose metabolism in 133 healthy late middleaged adults who provided ratings of positive affect twice over a
two-year period and then underwent FDG-PET scanning. We
hypothesized that greater positive affect would be positively
associated with cerebral glucose metabolism, a marker of brain
health.

Table 1. Participant characteristics
Variable
Age at initial CES-D
Age at FDG-PET scan
Female, %
Caucasian, %
Education (years)
Initial MMSE
FH positive, %
APOE 4 positive, %
Perceived health statusa
Anti-depressant use, %
CES-D totala
CES-D positive affecta
CES-D-16 depressive symptomsa

Participants (N ¼ 133)
59.29 (6.11)
63.22 (5.99)
71.4
97
16.97 (2.97)
29.47 (0.87)
66.9
40.6
3.81 (0.71)
30.8
5.89 (4.95)
10.64 (1.61)
4.52 (4.01)

a

Calculated as the mean across two visits.

CES-D, Center for the Epidemiologic Studies Depression; FDG-PET, fluorodeoxyglucose
positron emission tomography; FH, parental family history of Alzheimer’s disease;
APOE 4, Apolipoprotein Epsilon-4; MMSE, Mini-Mental Status Examination. Non-percentage values are sample means with standard deviations in parentheses.

data. The University of Wisconsin Institutional Review Board
approved all study procedures and each participant signed informed consent prior to participation.

Design
Participants completed the CES-D on two different visits scheduled approximately two years apart (mean visit 1 to visit 2 interval ¼ 26.63 months, SD ¼ 3.47) prior to the FDG-PET scan.
Participants then underwent FDG-PET scanning 20 months
after their second visit (mean visit 1 to FDG-PET scan interval ¼ 47.23 months; SD ¼15.46 and mean visit 2 to FDG-PET scan
interval ¼ 20.60 months; SD ¼ 15.85).

Self-report measures

Materials and methods
Participants
This study used data from the Wisconsin Registry for
Alzheimer’s Prevention (WRAP) cohort (Table 1), a longitudinal
registry of > 1500 cognitively healthy adults recruited in middleage and enriched for AD risk factors of APOE e4 carriage and parental family history of AD (Sager et al., 2005). Determination of
APOE e4 and FH status in this sample has been previously
described (Jonaitis et al., 2013; Koscik et al., 2014).
A total of 133 out of 178 asymptomatic late middle-aged
adults (mean age 59.29 years, SD ¼ 6.11, range ¼ 46.58–71.07,
71.4% female) were included in the current analyses if they had
completed a comprehensive neuropsychological battery, selfreport ratings of affect as indexed by the Center for
Epidemiologic Studies Depression Scale (CES-D), magnetic resonance imaging (MRI), FDG-PET; and were determined by neuropsychological evaluation and consensus review to be
cognitively normal, and absent of a major psychiatric diagnosis,
history of neurological disease and head trauma. Forty-five participants were not included in the analyses for the following
reasons: 14 declined the FDG-PET scan, 11 were lost to followup, nine had CES-D measurements that followed the FDG-PET
scan (see section labeled ‘Design’), four were MRI ineligible, four
had an abnormal FDG-PET scan and three were missing CES-D

The CES-D, a well-validated questionnaire composed of 20items designed to measure frequency of depressive symptoms
experienced over the past week (Radloff, 1977) was used to assess affect. Factor analytic research on the internal structure of
the CES-D typically yields a four-factor structure (Positive
Affect, Negative Affect, Somatic Symptoms and Interpersonal
Problems) (Shafer, 2006). This structure was tested and confirmed in the current study sample. The four statements comprising the positive affect subscale (‘I felt that I was just as good
as other people’; ‘I felt hopeful about the future’; ‘I was happy’; ‘I
enjoyed life’) have previously been shown to be associated with
beneficial health outcomes (Ostir 2000; Moskowitz, 2003) and
were used to assess positive affect in the current study. For
each item, participants were asked to use a four-point Likert
scale (e.g. rarely/none, some/little, occasionally/moderate,
most/all of the time; scored 0–3, respectively) to indicate how
often they experienced a particular statement. Scores ranged
from 0 to 12, with higher scores equating to a greater frequency
and/or level of positive affect. A mean positive affect score
based on their ratings at the two visits was calculated for each
participant as a measure of characteristic positive affect
(Dotson et al., 2009a,b). We included the remaining 16-items of
the CES-D (CES-D-16) to control for depressive symptoms
(Stansbury et al., 2006). Scores ranged from 0 to 48, with higher
scores equating to more depressive symptoms. For each
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participant, scores collected at each of the two visits were used
to calculate mean depressive symptoms. To assess perceived
health status at each visit participants were asked, ‘How would
you rate your current health?’ on a five-point Likert scale ranging from ‘Poor’ to ‘Excellent’, with higher scores equating to
greater perceived health. A mean score of perceived health status over the two visits was calculated and included to control
for potential confounding effects of ill health on positive affect
(Liu et al., 2016).

FDG-PET imaging
Each participant underwent FDG-PET imaging using the
Alzheimer’s Disease NeuroImaging Initiative protocol (Jagust
et al., 2010) including five mCi FDG injection with a 30-min uptake period followed by a 30 min acquisition. To reduce intersubject variability participants abstained from food, caffeine, tobacco and medication for a minimum of 4 h prior to scanning.
Post-processing involved frame-to-frame realignment and summation of the 30 min emission scans. Images were co-registered
to the T1-weighted image, spatially normalized to the ICBM 152
atlas and smoothed to 8 mm using SPM12 (www.fil.ion.ucl.ac.
uk/spm). Intensity normalization was achieved by calculating
the mean signal over the pons and cerebellar vermis (Jagust and
Landau, 2012; Knopman et al., 2013) producing scaled images for
each participant that were used in second level analyses.

MRI
T1-weighted images were acquired for the purpose of coregisteration of FDG-PET scans. Participants underwent scanning on
a General Electric 3.0 Tesla Discovery MR750 MRI system with
an eight-channel head coil (Excite HD Brain Coil, GE Healthcare).
T1-weighted images were acquired in the axial plane with a 3D
fast spoiled gradient-echo sequence using the following parameters: inversion time (TI) ¼ 450 ms; repetition time (TR) ¼ 8.1 ms;
echo time (TE) ¼ 3.2 ms; flip angle ¼ 12 ; acquisition matrix ¼ 256 mm  256 mm, field of view (FOV) ¼ 256 mm; slice
thickness ¼ 1.0 mm.

Family history and APOE 4 status
To verify the diagnosis of AD in the parent, parental medical records, autopsy reports or results of the dementia questionnaire
(Kawas et al., 1994) were obtained and reviewed by a multidisciplinary diagnostic consensus conference (Jonaitis et al., 2013;
Koscik et al., 2014; Sager et al., 2005). Absence of FH of AD was
verified through detailed medical history surveys and phone
interview with the participants. Genotyping for APOE e4 status
was done previously in WRAP and described elsewhere
(Johnson et al., 2011).

Statistical analyses
Associations between positive affect and glucose metabolism
were assessed using multiple regression analyses conducted in
SPM12. The model included positive affect as the main continuous predictor variable with FDG-PET as the dependent measure.
Age at visit 1, sex, depressive symptoms, anti-depressant use at
visit 1 and/or visit 2, perceived health status, family history of
AD, APOE e4 status, and interval between visit 1 CES-D and
scanning were treated as covariates (Table 1). No covariate exceeded a Pearson product correlation of 0.5. Voxel-wise analyses
were restricted to gray matter using an explicit mask made by
thresholding the International Consortium for Brain Mapping
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Tissue Probabilistic Atlases gray matter map at 0.20. This was
done to minimize type 1 errors, ensuring that voxels with less
than a 20% likelihood of being gray matter were not included in
analyses. Statistical parametric maps were thresholded at
P  0.001 (uncorrected) with a cluster extent threshold of > 100
contiguous voxels. Resulting clusters were considered significant if they surpassed a threshold of P ¼ 0.05, cluster-level
Family Wise Error (FWE) correction.

Results
Table 1 provides information on the participant characteristics
and self-report measures. Whole brain voxel-wise analysis revealed a significant main effect of positive affect on cerebral
glucose metabolism (P < 0.05 FWE cluster-corrected) in the bilateral posterior cingulate gyrus/precuneus; left angular/suparmarginal gyrus; left middle/inferior temporal gyrus and left
middle/frontal gyrus where greater positive affect was associated with higher cerebral glucose metabolism in these regions
(See Figure 1 and Table 2 for maxima and submaxima within
each cluster).

Discussion
The current study examined the novel association between
positive affect and cerebral glucose metabolism in a healthy
late middle-aged sample. Consistent with our hypothesis,
whole-brain voxel-wise analyses revealed a significant association between positive affect and cerebral glucose metabolism,
such that greater positive affect was positively associated with
relatively greater cerebral glucose metabolism within para-/limbic, frontal, temporal and parietal regions. Broadly, these regions have been implicated in functional neuroimaging studies
of affective processing (Blood et al., 1999; Damasio et al., 2000;
Davidson and Irwin, 1999; Duerden et al., 2013; Hofer et al., 2007;
Maddock et al., 2003; Phillips et al., 2008) and show changes in
glucose metabolism in depression (Fitzgerald et al., 2008; Su
et al., 2014), a disorder often characterized by low levels of positive affect (Watson and Clark, 1997; Wichers et al., 2012). In addition, regional grey matter volume in the precuneus,
parahippocampus, medial prefrontal cortex and insula correlate
with models of well-being (Kong et al., 2015; Lewis et al., 2014);
which are constructs related to positive affect and often found
to be associated with beneficial health outcomes (Boehm and
Kubzansky, 2012; Ryan and Deci, 2001).
The positive association between positive affect and glucose
metabolism across para-/limbic, frontal, temporal and parietal
regions may be informed by a constructionist perspective, in
which a variety of more ‘basic psychological operations’ from a
complex array of distributed brain networks (Lindquist et al.,
2012) are involved in the monitoring, processing and generation
of affect (Damasio et al., 2000; Davidson, 2004; Lindquist et al.,
2015). As part of the paralimbic cortex, the PCC/precuneus, parahippocampus and insula each play a role as integrative hubs for
a variety of functional processes (Buckner et al., 2009) and are
involved in affective processing (Blood et al., 1999; Damasio
et al., 2000; Davidson and Irwin, 1999; Duerden et al., 2013;
Maddock et al., 2003; Phillips et al., 2008). The PCC/precuneus is a
highly active metabolic region (Raichle et al., 2001) involved in
facilitating the integration of interoceptive and exteroceptive
stimuli across a spectrum of attention (Leech and Sharp, 2014).
The core underlying function of the parahippocampus is to bind
contextual features (e.g. emotional content of a situation or experience) and link these features to a larger network of relevant
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Table 2. Brain regions that showed a significant main effect of positive affect on glucose metabolism using voxel-wise analyses
Cluster location

Hemisphere

k

x

y

z

Peak t

P (FWE)

Posterior cingulate gyrus (23, 29, 31), precuneus (7)
Angular/supramarginal gyrus (39, 40), insula (13), transverse temporal gyrus (41)
Middle temporal gyrus (21, 22), para-hippocampal gyrus, hippocampal gyrus,
inferior temporal gyrus (20)
Middle frontal gyrus (10), superior frontal gyrus (10/11), anterior cingulate gyrus (32)

B
L
L

1832
1320
738

6
38
54

60
54
42

16
30
6

4.76
4.63
4.43

0.001
0.003
0.031

L

652

30

50

0

4.38

0.044

X, Y, Z coordinates of the peak voxel of each cluster are presented in Montreal Neurological Institute (MNI) space. Corresponding Brodmann areas are in parentheses.
B ¼ Bilateral; L, Left; k, number of contiguous voxels in cluster.

Fig. 1. Statistical parametric maps were thresholded at an uncorrected voxelwise threshold of P<0.001 with a cluster extent threshold of > 100 contiguous voxels.
Resulting clusters were considered significant if they surpassed cluster-level threshold of P<0.05 with a Family Wise Error correction for multiple comparisons. Sagittal
and coronal slices were derived from a normalized T1 anatomical image.

memories in the association cortex (Aminoff et al., 2013;
Eichenbaum et al., 2007). The insula is positioned amidst these
regions with specific connections to the parahippocampus,
where it is involved in integrating internal homeostatic, visceral
and sensory signals (Craig, 2009, 2010; Nagai et al., 2007; Suzuki,
2009). The frontal regions spanning the middle and superior
frontal gyrus, and anterior cingulate gyrus, have extensive connections to the para-/limbic system and subcortical structures
€
(Ongür
and Price, 2000), and support range of cognitive functions relevant to affective processing including integration of
sensory and visceral information, evaluation and attribution of
affective stimuli and decision-making and self-regulation
(Bechara et al., 2000; Ochsner and Gross, 2005; Phillips et al.,
2008). Lastly, the left angular/supramarginal gyri are also
involved in emotional processing (Hofer et al., 2007) and considered a heteromodal convergence zone supporting the integration and conceptualization of information from sensory,
language and memory subsystems (Binder and Desai, 2011;
Ciaramelli et al., 2008; Seghier, 2013). Taken together, we broadly
suggest, that affect emerges when integrated representations
(e.g. PCC/precuneus; angular/supramarginal gyrus; insula) of internal and external sensory stimuli based on contextual information from memories (e.g. para-/hippocampal gyrus) are
deemed relevant and meaningful to the individual (e.g. prefrontal/frontal cortices). Of course, this is only a partial account
based on our findings, thus evidence of additional regions (e.g.
amygdala) and models of affective processing (e.g. lateralization; localist) (Davidson and Irwin, 1999; Rohr et al., 2013) deserve consideration.
Within our late middle-aged sample, the association between positive affect and cerebral glucose metabolism was
observed in a number of brain regions that are known to exhibit
progressive reductions in metabolism in prodromal stages of

AD, including the PCC, precuneus, para-/hippocampus and temporal/parietal (Buckner et al., 2005; Chetelat et al., 2003;
Minoshima et al., 1997; Mosconi, 2005; Mosconi et al., 2009;
Protas et al., 2013). Affective changes associated with depressive
symptoms may be an important predictor of cognitive decline
and dementia (da Silva et al., 2013; Ownby et al., 2006; Stepaniuk
et al., 2008), and have been shown to correspond to alterations
in brain volume and cerebral blood flow in vulnerable brain regions of older adults (Dotson et al., 2009a,b; Ries et al., 2009).
Given that we controlled for depressive symptoms, the relationship between positive affect and cerebral glucose metabolism,
notably in brain regions that support integrative functions
involved in affective processing, suggests positive affect may be
an important factor associated with brain health in late midlife,
when neuropathological processes are only beginning to
emerge and may still be modifiable (Jessen et al., 2014; Sperling
et al., 2011).
This may have implications for interventions aimed at
increasing and/or maintaining positive affect (Layous et al.,
2011; Proyer et al., 2014; Seligman et al., 2005; Sin and
Lyubomirsky, 2009). Specifically, the ‘broaden and build’ theory
posits that positive affect expands the scope of ‘thought-action
repertoires’ (e.g. exploration, creative problem solving, cognitive
flexibility, broadening of attention), leading to a building of resources and beneficial outcomes (Fredrickson, 2001, 2013;
Fredrickson et al., 2008). Consistent with this theory, positive affect is associated with reduced morbidity for a variety of known
risk factors (e.g. cardiovascular; chronic stress) for AD (Boehm
and Kubzansky, 2012; Pressman and Cohen, 2005; Steptoe et al.,
2005), enhanced cognitive functioning (Ashby et al., 1999;
Carpenter et al., 2013; Yang et al., 2013), and as our work suggests, relatively higher levels of cerebral glucose metabolism in
regions vulnerable to early neuropathological changes. Thus,
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interventions targeting positive affect could have potential in
mitigating pathological processes associated with cognitive and
functional decline through increasing flexible and adaptive responses (e.g. thought-action repertoires) to environmental demands and/or optimizing cerebral glucose metabolism within
these particular brain regions. Of course, this is highly speculative, and warrants examination with more sophisticated modeling techniques and measures to further clarify the causal
relationships between these variables.
There are potential limitations of our study that deserve
mentioning. First, because over half the participants in this
study have a family history of AD (66.9%), were late middleaged (m ¼ 59.29 yrs-old), highly educated (m ¼ 16.97 yrs) and predominantly Caucasian (97.0%), the generalizability of our results
is limited and would benefit from replication in more diverse
samples. Second, while we included a measure of perceived
health, which has been shown to attenuate the association between happiness and all-cause mortality (Liu et al., 2016), we did
not examine a variety of specific psychological (e.g. personality,
coping style), health (e.g. cardiovascular, endocrine, exercise)
and social factors (e.g. social stress and support, income) that
may be associated with positive affect (Lyubomirsky et al., 2005).
Lastly, we speculate based on the literature regarding possible
connectivity between regions, thus future analyses employing
connectivity methods for FDG-PET data would be useful.
In conclusion, this study provides initial evidence that positive affect is associated with cerebral glucose metabolism in
brain regions that support a variety of integrative functions
involved in affective processing. A number of these regions are
also known to be vulnerable to early progressive neurodegenerative changes, and therefore lay the foundation for future studies investigating the longitudinal relationship between positive
affect and factors associated with pathological aging and brain
health. Additionally, our findings highlight the potential for
interventions aimed at increasing and/or maintaining positive
affect, particularly in late-middle aged adults when early preclinical neuropathological processes may still be modifiable.
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da Silva, J., Gonçalves-Pereira, M., Xavier, M., MukaetovaLadinska, E.B. (2013). Affective disorders and risk of developing
dementia: systematic review. The British Journal of Psychiatry,
202(3), 177–86.
Damasio, A.R., Grabowski, T.J., Bechara, A., et al. (2000).
Subcortical and cortical brain activity during the feeling of
self-generated emotions. Nature Neuroscience, 3(10), 1049–56.
Danner, D.D., Snowdon, D.A., Friesen, W.V. (2001). Positive emotions in early life and longevity: findings from the nun study.
Journal of Personality and Social Psychology, 80(5), 804–13.
Retrieved
from:
http://www.ncbi.nlm.nih.gov/pubmed/
11374751.
Davidson, K.W., Mostofsky, E., Whang, W. (2010). Don’t worry, be
happy: positive affect and reduced 10-year incident coronary
heart disease: the Canadian Nova Scotia Health Survey.
European Heart Journal, 31(9), 1065–70.
Davidson, R.J. (2004). Well-being and affective style: neural substrates
and
biobehavioural
correlates.
Philosophical
Transactions: Biological Sciences, 359(1449), 1395–411. Retrieved
from: http://www.jstor.org/stable/4142143.
Davidson, R.J., Irwin, W. (1999). The functional neuroanatomy of
emotion and affective style. Trends in Cognitive Sciences, 3(1),
11–21. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/
10234222.

998

|

Social Cognitive and Affective Neuroscience, 2017, Vol. 12, No. 6

Diener, E., Chan, M.Y. (2011). Happy people live longer: subjective
well-being contributes to health and longevity. Applied
Psychology: Health and Well-Being, 3(1), 1–43.
Dotson, V.M., Beason-Held, L., Kraut, M.A., Resnick, S.M. (2009a).
Longitudinal study of chronic depressive symptoms and regional cerebral blood flow in older men and women.
International Journal of Geriatric Psychiatry, 24(8), 809–19.
Dotson, V.M., Davatzikos, C., Kraut, M.A., Resnick, S.M. (2009b).
Depressive symptoms and brain volumes in older adults: a
longitudinal magnetic resonance imaging study. Journal of
Psychiatry & Neuroscience, 34(5), 367–75. Retrieved from: http://
www.ncbi.nlm.nih.gov/pubmed/19721847.
Drevets, W.C., Price, J.L., Simpson, J.R., Jr, et al. (1997). Subgenual
prefrontal cortex abnormalities in mood disorders. Nature,
386(6627), 824–7.
Duerden, E.G., Arsalidou, M., Lee, M., Taylor, M.J. (2013).
Lateralization of affective processing in the insula. Neuroimage,
78, 159–75.
Dukart, J., Kherif, F., Mueller, K. et al. (2013). Generative FDG-PET
and MRI model of aging and disease progression in
Alzheimer’s disease. PLOS Computational Biology, 9(4), e1002987.
Eichenbaum, H., Yonelinas, A.P., Ranganath, C. (2007). The medial temporal lobe and recognition memory. Annual Review of
Neuroscience, 30, 123–52.
Fitzgerald, P.B., Laird, A.R., Maller, J., Daskalakis, Z.J. (2008). A
meta-analytic study of changes in brain activation in depression. Human Brain Mapping, 29(6), 683–95.
Folkman, S., Moskowitz, J.T. (2000). Positive affect and the other
side of coping. American Psychologist, 55(6), 647–54. Retrieved
from: http://www.ncbi.nlm.nih.gov/pubmed/10892207.
Fredrickson, B.L. (2001). The role of positive emotions in positive
psychology. The broaden-and-build theory of positive emotions. American Psychologist, 56(3), 218–26. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/11315248.
Fredrickson, B.L. (2013). Positive emotions broaden and build.
Advances in Experimental Social Psychology, 47(1), 53.
Fredrickson, B.L., Cohn, M.A., Coffey, K.A., Pek, J., Finkel, S.M.
(2008). Open hearts build lives: positive emotions, induced
through loving-kindness meditation, build consequential personal resources. Journal of Personality and Social Psychology,
95(5), 1045.
Fredrickson, B.L., Tugade, M.M., Waugh, C.E., Larkin, G.R. (2003).
What good are positive emotions in crisis? A prospective study
of resilience and emotions following the terrorist attacks on
the United States on September 11th, 2001. Journal of Personality
and Social Psychology, 84(2), 365–76.
Hofer, A., Siedentopf, C.M., Ischebeck, A., et al. (2007). Sex differences in brain activation patterns during processing of positively and negatively valenced emotional words. Psychological
Medicine, 37(01), 109–19.
Jagust, W.J., Bandy, D., Chen, K., et al. (2010). The Alzheimer’s
Disease neuroimaging initiative positron emission tomography core. Alzheimer’s & Dementia, 6(3), 221–9.
Jagust, W.J., Landau, S.M. (2012). Apolipoprotein E, not fibrillar
b-amyloid, reduces cerebral glucose metabolism in normal
aging. Journal of Neuroscience, 32(50), 18227–33.
Jessen, F., Amariglio, R.E., van Boxtel, M., et al. (2014). A conceptual framework for research on subjective cognitive decline in
preclinical Alzheimer’s disease. Alzheimer’s & Dementia, 10(6),
844–52.
Johnson, S.C., La Rue, A., Hermann, B.P., et al. (2011). The effect of
TOMM40 poly-T length on gray matter volume and cognition
in middle-aged persons with APOE e3/e3 genotype. Alzheimer’s

& Dementia: The Journal of the Alzheimer’s Association, 7(4),
456–65.
Jonaitis, E., La Rue, A., Mueller, K.D., Koscik, R.L., Hermann, B.,
Sager, M.A. (2013). Cognitive activities and cognitive performance in middle-aged adults at risk for Alzheimer’s disease.
Psychology and Aging, 28(4), 1004–14.
Kalpouzos, G., Chetelat, G., Baron, J.C., et al. (2009). Voxel-based
mapping of brain gray matter volume and glucose metabolism
profiles in normal aging. Neurobiology of Aging, 30(1), 112–24.
Kashdan, T.B., Roberts, J.E. (2004). Trait and state curiosity in the
genesis of intimacy: differentiation from related constructs.
Journal of Social and Clinical Psychology, 23(6), 792.
Kawas, C., Segal, J., Stewart, W.F., Corrada, M., Thal, L.J. (1994). A
validation study of the dementia questionnaire. Archives of
Neurology, 51(9), 901–6.
Knopman, D.S., Jack, C.R., Wiste, H.J., et al. (2013). Selective worsening of brain injury biomarker abnormalities in cognitively
normal elderly with b-amyloidosis. JAMA Neurology, 70(8),
1030–8. doi:10.1001/jamaneurol.2013.182.
Kong, F., Ding, K., Yang, Z., et al. (2015). Examining gray matter
structures associated with individual differences in global life
satisfaction in a large sample of young adults. Social Cognitive
and Affective Neuroscience, 10(7), 952–60.
Koscik, R.L., La Rue, A., Jonaitis, E.M., et al. (2014). Emergence of
mild cognitive impairment in late middle-aged adults in the
Wisconsin Registry for Alzheimer’s prevention. Dementia and
Geriatric Cognitive Disorders, 38(1–2), 16–30.
Krijthe, B.P., Walter, S., Newson, R.S., Hofman, A., Hunink, M.G.,
Tiemeier, H. (2011). Is positive affect associated with survival?
A population-based study of elderly persons. American Journal
of Epidemiology, 73(11), 1298–307.
Layous, K., Chancellor, J., Lyubomirsky, S., Wang, L.,
Doraiswamy, P.M. (2011). Delivering happiness: translating
positive psychology intervention research for treating major
and minor depressive disorders. The Journal of Alternative and
Complementary Medicine, 17(8), 675–83.
Leech, R., Sharp, D.J. (2014). The role of the posterior cingulate
cortex in cognition and disease. Brain, 137(Pt 1), 12–32.
Levy, B.R., Slade, M.D., Kunkel, S.R., Kasl, S.V. (2002). Longevity
increased by positive self-perceptions of aging. Journal of
Personality and Social Psychology, 83(2), 261–70. Retrieved from:
http://www.ncbi.nlm.nih.gov/pubmed/12150226.
Lewis, G.J., Kanai, R., Rees, G., Bates, T.C. (2014). Neural correlates
of the ‘good life’: eudaimonic well-being is associated with insular cortex volume. Social Cognitive and Affective Neuroscience,
9(5), 615–8.
Lindquist, K.A., Satpute, A.B., Wager, T.D., Weber, J., Barrett, L.F.
(2015). The brain basis of positive and negative affect: evidence
from a meta-analysis of the human neuroimaging literature.
Cerebral Cortex, 5, 1910–22.
Lindquist, K.A., Wager, T.D., Kober, H., Bliss-Moreau, E., Barrett,
L.F. (2012). The brain basis of emotion: a meta-analytic review.
Behavioral and Brain Sciences, 35(03), 121–43.
Liu, B., Floud, S., Pirie, K., et al. (2016). Does happiness itself directly affect mortality? The prospective UK Million Women
Study. Lancet, 387, 874–81. doi:10.1016/S0140-6736(15)01087-9.
Lyubomirsky, S., King, L., Diener, E. (2005). The benefits of frequent positive affect: does happiness lead to success?
Psychological Bulletin, 131(6), 803–55.
Maddock, R.J., Garrett, A.S., Buonocore, M.H. (2003). Posterior cingulate cortex activation by emotional words: fMRI evidence
from a valence decision task. Human Brain Mapping, 18(1),
30–41.

C. R. Nicholas et al.

Minoshima, S., Giordani, B., Berent, S., Frey, K.A., Foster, N.L.,
Kuhl, D.E. (1997). Metabolic reduction in the posterior cingulate
cortex in very early Alzheimer’s disease. Annals of Neurology,
42(1), 85–94.
Mosconi, L. (2005). Brain glucose metabolism in the early and
specific diagnosis of Alzheimer’s disease. FDG-PET studies in
MCI and AD. European Journal of Nuclear Medicine and Molecular
Imaging, 32(4), 486–510.
Mosconi, L., Mistur, R., Switalski, R., et al. (2009). FDG-PET
changes in brain glucose metabolism from normal cognition
to pathologically verified Alzheimer’s disease. European Journal
of Nuclear Medicine and Molecular Imaging, 36(5), 811–22.
Moskowitz, J.T. (2003). Positive affect predicts lower risk of AIDS
mortality. Psychosomatic Medicine, 65(4), 620–6. Retrieved from:
http://www.ncbi.nlm.nih.gov/pubmed/12883113.
Nagai, M., Kishi, K., Kato, S. (2007). Insular cortex and neuropsychiatric disorders: a review of recent literature. European
Psychiatry, 22(6), 387–94.
Ochsner, K.N., Gross, J.J. (2005). The cognitive control of emotion.
Trends in Cognitive Sciences, 9(5), 242–9.
€
Ongür,
D., Price, J. (2000). The organization of networks within
the orbital and medial prefrontal cortex of rats, monkeys and
humans. Cerebral Cortex, 10(3), 206–19.
Ostir, G.V., Markides, K.S., Black, S.A., Goodwin, J.S. (2000).
Emotional well-being predicts subsequent functional independence and survival. Journal of the American Geriatrics Society,
48(5), 473–8. Retrieved from: http://www.ncbi.nlm.nih.gov/
pubmed/10811538.
Ostir, G.V., Markides, K.S., Peek, M.K., Goodwin, J.S. (2001). The
association between emotional well-being and the incidence
of stroke in older adults. Psychosomatic Medicine, 63(2), 210–5.
Retrieved
from:
http://www.ncbi.nlm.nih.gov/pubmed/
11292267.
Ownby, R.L., Crocco, E., Acevedo, A., John, V., Loewenstein, D.
(2006). Depression and risk for Alzheimer disease: systematic
review, meta-analysis, and metaregression analysis. Archives
of General Psychiatry, 63(5), 530–8.
Pardo, J.V., Lee, J.T., Sheikh, S.A., et al. (2007). Where the brain
grows old: decline in anterior cingulate and medial prefrontal
function with normal aging. Neuroimage, 35(3), 1231–7.
Petit-Taboue, M., Landeau, B., Desson, J., Desgranges, B., Baron, J.
(1998). Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage, 7(3), 176–84.
Phillips, M.L., Ladouceur, C.D., Drevets, W.C. (2008). A neural
model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Molecular Psychiatry, 13(9),
833–57.
Pressman, S.D., Cohen, S. (2005). Does positive affect influence
health? Psychological Bulletin, 131(6), 925.
Protas, H.D., Chen, K., Langbaum, J.B., et al. (2013). Posterior cingulate glucose metabolism, hippocampal glucose metabolism,
and hippocampal volume in cognitively normal, late-middleaged persons at 3 levels of genetic risk for Alzheimer disease.
JAMA Neurology, 70(3), 320–5.
Proyer, R.T., Gander, F., Wellenzohn, S., Ruch, W. (2014). Positive
psychology interventions in people aged 50–79 years: longterm effects of placebo-controlled online interventions on
well-being and depression. Aging & Mental Health, 18(8),
997–1005.
Radloff, L.S. (1977). The CES-D scale: a self-report depression
scale for research in the general population. Applied
Psychological Measurement, 1(3), 385–401.

|

999

Raichle, M.E., MacLeod, A.M., Snyder, A.Z., Powers, W.J.,
Gusnard, D.A., Shulman, G.L. (2001). A default mode of brain
function. Proceedings of the National Academy of Sciences of the
United States of America, 98(2), 676–82.
Ries, M.L., Wichmann, A., Bendlin, B.B., Johnson, S.C. (2009).
Posterior cingulate and lateral parietal gray matter volume in
older adults with depressive symptoms. Brain Imaging and
Behavior, 3(3), 233–9.
Rohr, C.S., Okon-Singer, H., Craddock, R.C., Villringer, A.,
Margulies, D.S. (2013). Affect and the brain’s functional organization: a resting-state connectivity approach. PLoS ONE, 8(7),
e68015.
Ruvolo, A.P. (1998). Marital well-being and general happiness of
newlywed couples: relationships across time. Journal of Social
and Personal Relationships, 15(4), 470–89.
Ryan, R.M., Deci, E.L. (2001). On happiness and human potentials: a review of research on hedonic and eudaimonic wellbeing. Annual Review of Psychology, 52 (1), 141–166.
Sager, M.A., Hermann, B., La Rue, A. (2005). Middle-aged children
of persons with Alzheimer’s disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer’s
Prevention. Journal of Geriatric Psychiatry and Neurology, 18(4),
245–9.
Seghier, M.L. (2013). The angular gyrus multiple functions and
multiple subdivisions. The Neuroscientist, 19(1), 43–61.
Seligman, M.E., Steen, T.A., Park, N., Peterson, C. (2005). Positive
psychology progress: empirical validation of interventions.
American Psychologist, 60(5), 410.
Seminowicz, D., Mayberg, H., McIntosh, A., et al. (2004). Limbic–
frontal circuitry in major depression: a path modeling metanalysis. Neuroimage, 22(1), 409–18.
Shafer, A.B. (2006). Meta-analysis of the factor structures of four
depression questionnaires: Beck, CES-D, Hamilton, and Zung.
Journal of Clinical Psychology, 62(1), 123–46.
Sin, N.L., Lyubomirsky, S. (2009). Enhancing well-being and alleviating depressive symptoms with positive psychology interventions: a practice-friendly meta-analysis. Journal of Clinical
Psychology, 65(5), 467–87.
Sperling, R.A., Aisen, P.S., Beckett, L.A., et al. (2011). Toward
defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s
Association workgroups on diagnostic guidelines for
Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 280–92.
Stansbury, J.P., Ried, L.D., Velozo, C.A. (2006). Unidimensionality
and bandwidth in the Center for Epidemiologic Studies
Depression (CES-D) scale. Journal of Personality Assessment,
86(1), 10–22.
Stepaniuk, J., Ritchie, L., Tuokko, H.A. (2008). Neuropsychiatric
impairments as predictors of mild cognitive impairment, dementia, and Alzheimer’s disease. American Journal of
Alzheimer’s Disease and Other Dementias, 23, 326–33.
Steptoe, A., Deaton, A., Stone, A.A. (2015). Subjective wellbeing,
health, and ageing. The Lancet, 385(9968), 640–8.
Steptoe, A., Wardle, J., Marmot, M. (2005). Positive affect and
health-related neuroendocrine, cardiovascular, and inflammatory processes. Proceedings of the National Academy of Sciences
of the United States of America, 102(18), 6508–12.
Su, L., Cai, Y., Xu, Y., Dutt, A., Shi, S., Bramon, E. (2014). Cerebral
metabolism in major depressive disorder: a voxel-based metaanalysis of positron emission tomography studies. BMC
Psychiatry, 14(1), 1.
Suzuki, W. (2009). Comparative analysis of the cortical afferents,
intrinsic projections and interconnections of the parahippocampal region in monkeys and rats. In: Gazzaniga, M.S., editor.

1000

| Social Cognitive and Affective Neuroscience, 2017, Vol. 12, No. 6

The Cognitive Neurosciences, pp.659–774. Cambridge, MA: MIT
Press.
Watson, D., Clark, L.A. (1997). Measurement and mismeasurement of mood: recurrent and emergent issues. Journal of
Personality Assessment, 68(2), 267–96.
Wichers, M., Lothmann, C., Simons, C.J., Nicolson, N.A., Peeters,
F. (2012). The dynamic interplay between negative and positive
emotions in daily life predicts response to treatment in depression: a momentary assessment study. British Journal of
Clinical Psychology, 51(2), 206–22.

Wright, T.A., Staw, B.M. (1999). Affect and favorable work outcomes: Two longitudinal tests of the happy-productive worker
thesis. Journal of Organizational Behavior, 20(1), 1–23.
Yang, H., Yang, S., Isen, A.M. (2013). Positive affect improves
working memory: implications for controlled cognitive processing. Cognition & Emotion, 27(3), 474–82.
Yoshizawa, H., Gazes, Y., Stern, Y., Miyata, Y., Uchiyama, S.
(2014). Characterizing the normative profile of 18F-FDG PET
brain imaging: sex difference, aging effect, and cognitive reserve. Psychiatry Research, 221(1), 78–85.

